Discussion In this database study, treatment with semaglutide (against sitagliptin, a placebo proxy) led to a reduced risk of MACE, and tirzepatide (against dulaglutide) demonstrated a similar risk reduction in patients at elevated cardiovascular risk with obesity and type 2 diabetes
Therefore, we recommend you review your diet plan and activity level to ensure youre pairing your semaglutide treatment with healthy lifestyle choices
Each mechanism addition adds roughly 5-7 percentage points
For guidance on managing this, our resource on GLP-1 constipation relief strategies offers practical solutions that apply to probiotic-induced constipation as well
This includes the cost of your provider visits, medication, supplies, and ongoing support.
Foundayo, Lillys oral GLP-1 pill for weight loss and obesity, is the most important near-term commercial catalyst